PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 181 (xsd:integer)
nif:isString
  • Disease progression was stopped in a few hours after a combination of TNF-α antagonist infliximab with interleukin (IL)-6 receptor antagonist tocilizumab single-dose administration.
rdf:type